Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of First-Trimester Maternal Serum Resistin in Hyperemesis Gravidarum

NCT06757374 is registered in ClinicalTrials.gov with Dr. Lutfi Kirdar Kartal Training and Research Hospital as lead sponsor.

NCT NCT06757374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06757374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of First-Trimester Maternal Serum Resistin in Hyperemesis Gravidarum
Lead sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2022
Completion date
June 1, 2023
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus (gdm), hyperemesis gravidarum - severe, resistin